glp-1 alzheimer's 2024 Older drug may help protect brains of patients Penn Holderness, a family influencer,

The setbacks led to change at the top: Novo announced last month that CEO Lars Fruergaard Jorgensen will step down

Tirzepatide (Zepbound / Mounjaro) Tirzepatide activates both GLP-1 and GIP receptors simultaneously a dual mechanism that produces significantly greater weight loss than GLP-1 alone

Weghuber D, Forslund A, Ahlstrom H, Alderborn A, Bergstrom K, Brunner S, et al

With both medical and non-medical options to consider, along with various injections, supplements, and more, you are sure to find something that matches your preferences and needs

Novo Nordisk price cuts create competitive headwinds The primary factor driving recent weakness stems from escalating price competition in GLP-1 obesity treatments, where Hims & Hers is attempting to establish a foothold